Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new report from Memorial Sloan-Kettering Cancer Center has documented patient outcomes at 10 years after high-dose, intensity-modulated radiation therapy (IMRT) for men initially diagnosed with clinically localized prostate cancer.
Filed under: Management, Treatment | Tagged: high-dose, IMRT, intensity-modulated radtiation therapy, localized, outcome | 2 Comments »
ACR 03-12 is a Phase II clinical trial designed by the American College of Radiology to test the safety and efficacy of 82 GyE (Gray equivalent) delivered using conformal proton beam radiation therapy (PBRT) for the treatment of localized prostate cancer.
Filed under: Management, Treatment | Tagged: high-dose, PBRT, proton beam radiation therapy, toxicity | 2 Comments »
Historically there have been few really compelling data available to support the use of an additional or alternative antiandrogen as a second-line agent to extend either progression-free or overall survival of castration-resistant prostate cancer (CRPC) patients who progress after first-line hormone therapy (whether they have been treated by orchiectomy or medical castration with an LHRH [...]
Filed under: Management, Treatment | Tagged: antiandrogen, bicalutamide, high-dose, hormone, second-line, therapy | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site